SAN DIEGO, CA--(Marketwire - Dec 5, 2012) - Inviv
Post# of 28526
Posted On: 12/05/2012 9:25:02 AM
SAN DIEGO, CA--(Marketwire - Dec 5, 2012) - Invivoscribe Technologies, Inc. (San Diego, California) announced today that it has entered into an agreement with Takara Bio, Inc. (Otsu, Shiga, Japan) under which it has been granted a series of licenses to facilitate and conduct patent covered tests for the presence of internal tandem duplication (ITD) mutations in the FLT3 gene.
View More
View More
(0)
(0)Scroll down for more posts ▼